Astellas US LLC v. Hospira Inc.
1:12-cv-00652
Overview
Parties
Plaintiff
Item Development AB NPE (Individual / Inventor)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,731,296 A Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,449,665 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,534,504 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 77,951,685 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 3,024,587 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 13,830,687 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,104,859 A | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 5,231,086 A | US Continuation / Sibling | View Official Patent → |
Astellas US LLC v. Fresenius Kabi USA LLC
King Pharmaceuticals Research and Development, Inc. v. SICOR Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5731296
Selective vasodilation by continuous adenosine infusion
|
Filed: 1993-03-15
Issued: 1998-03-24
|
Expired (Term Ended)
Expires: 2013-03-15
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).